Showing results (41-50 of 343) with videos related to
Sort By:
Pageof 35
Plos One|April 10, 2014
Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancersMichael T Spiotto, Ralph R WeichselbaumMolecular Cancer Therapeutics|February 23, 2018
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung CancersSean P Pitroda, Melinda E Stack, Gene-Fu Liu, et al.JAMA Oncology|July 20, 2023
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical TrialRohan R Katipally, Carlos A Martinez, Siân A Pugh, et al.The Journal of Experimental Medicine|January 26, 2021
Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiationKaiting Yang, Yuzhu Hou, Yuan Zhang, et al.RNA (New York, N.Y.)|December 24, 2024
N 6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunityLiangliang Wang, Ralph R Weichselbaum, Chuan HeAdvanced Materials (Deerfield Beach, Fla.)|December 16, 2022
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor EfficacyWenyao Zhen, Ralph R Weichselbaum, Wenbin LinOncotarget|April 2, 2016
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAsDiana Rose E Ranoa, Akash D Parekh, Sean P Pitroda, et al.Cancer|May 21, 2016
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)Anthony C Wong, Sydeaka P Watson, Sean P Pitroda, et al.Endocrine-Related Cancer|February 16, 2022
Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumorsOlga Lakiza, Julian Lutze, Alyx Vogle, et al.Nature Clinical Practice. Gastroenterology & Hepatology|November 26, 2008
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?Ruchika Gutt, Stanley L Liauw, Ralph R WeichselbaumPageof 35